(Press-News.org) MINNEAPOLIS – Do you want to improve your brain health? Neurologists, the experts in brain health, have a plan. The American Academy of Neurology (AAN), the world’s largest association of neurologists and neuroscience professionals with over 40,000 members, is sharing its vision to improve the nation’s brain health by 2050. The new vision is part of a new AAN position statement on brain health, published online September 20, 2023, in Neurology®, the medical journal of the American Academy of Neurology.
The AAN’s vision for national brain health by 2050 includes:
Brain health research that leads to scientific breakthroughs
Preventive neurology as a thriving cross-disciplinary field
Brain health practice guidelines that are available for all ages
Brain health visits which become a standard of preventive care
Brain health education that is widely available and public engagement is high
A National Brain Health Plan established to guide research, care, and public engagement priorities
“Your brain controls every aspect of your life, so it’s important to keep it as healthy as possible,” said American Academy of Neurology President Carlayne E. Jackson, MD, FAAN. “The American Academy of Neurology, which has promoted brain health for decades through its advocacy and public outreach, is proud to stand united with a coalition of multidisciplinary stakeholders as we pursue a plan to improve brain health across each stage of your life.”
Driven by neurology expert consensus, the AAN newly defines brain health as a continuous state of attaining and maintaining the optimal neurologic function that best supports one’s physical, mental and social well-being through every stage of life.
The new position statement explains that brain health is crucial to optimizing both the function and well-being of every person at each stage of life and is key to both individual and social progress.
Neurologists treat diseases of the brain, and as brain health specialists they can advance brain health through preventive neurology. Preventive neurology offers strategies to prevent or slow the progression of brain disease. Jackson said, “Optimizing brain health with preventive care, accelerating scientific discovery and advancing public policy will improve brain health for all.”
The position statement will be presented at the 2023 AAN Brain Health Summit being held on Thursday, September 21, which will bring together nearly 150 leaders in brain health, representing dozens of academic and research organizations, professional medical societies and patient-centric associations, as well as key public and private sector stakeholders and United States policymakers as they continue to collaborate on shaping the future of brain health.
Learn more about brain health at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram.
When posting to social media channels about this position statement, we encourage you to use the hashtags #Neurology and #BrainHealth.
The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 40,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.
For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter, Instagram, LinkedIn and YouTube.
END
A brighter brain future for all: AAN sets new vision for brain health by 2050
2023-09-20
ELSE PRESS RELEASES FROM THIS DATE:
St. Jude refines definition and hones treatment of hyperdiploid leukemia
2023-09-20
(Memphis, Tenn.— Sept. 20, 2023) Hyperdiploidy is a genetic condition observed in cancer cells, where the cells contain more chromosomes than usual. The condition is particularly prevalent in childhood B-cell acute lymphoblastic leukemia (B-ALL), the most common form of pediatric cancer. To bring clarity to the field, researchers at St. Jude Children’s Research Hospital worked to better define this type of ALL in the context of modern therapy to more accurately predict patient outcomes and guide treatment decisions. The findings were published today in the Journal of Clinical ...
USC develops new preclinical system to better turn lab discoveries into effective treatments
2023-09-20
It is an all-too-common fact that potential drugs can look extremely promising in preclinical laboratory testing but fail when it comes to effectively treating humans. To better translate promising lab findings into effective new treatments, a team of researchers from the Keck School of Medicine of USC, supported by the National Institutes of Health, has developed, and tested, an innovative new system for conducting preclinical research on six potential new stroke treatments, identifying the strongest candidate for further study.
“We now have a feasible preclinical research system ...
Health organizations host Forum on Innovation and the Health Care Workforce
2023-09-20
The American College of Cardiology (ACC), NCD Alliance and World Heart Federation (WHF), with support from Viatris, brought together leaders in global health and technology for a “Enhancing the Health Workforce Through Innovation,” forum yesterday in New York. The event was held in advance of the 78th session of the U.N. General Assembly discussion on the need for universal health coverage to improve global access to care and reduce the out-of-pocket burden of rising health care costs.
“ACC has been committed to improving health care for all ...
DPP4 inhibitors for target therapy resistance in renal cell carcinoma
2023-09-20
“[...] we demonstrated that DPP4 inhibition increased sunitinib efficacy in DPP4-high RCC spheroids and DPP4 was upregulated in sunitinib-resistant RCC cells.”
BUFFALO, NY- September 20, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on September 15, 2023, entitled, “Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma.”
In their new editorial, researchers Kuniko Horie and Satoshi Inoue from Saitama Medical University and Tokyo Metropolitan Institute for Geriatrics and Gerontology discuss renal cell carcinoma (RCC) — a major ...
DNA damage-induced senescence model in osteoarthritic chondrocytes
2023-09-20
“This etoposide-induced senescence model may help investigate the initiation of cellular senescence in chondrocytes [...]”
BUFFALO, NY- September 20, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 17, entitled, “Development of a DNA damage-induced senescence model in osteoarthritic chondrocytes.”
Senescent cells (SnCs) have been described to accumulate in osteoarthritis (OA) joint tissues in response to injury, thereby participating in OA development and progression. However, clinical therapeutic approaches targeting SnCs using senolysis, ...
Socially vulnerable populations are disproportionately exposed to wildfires in the West, study finds
2023-09-20
CORVALLIS, Ore. – People experiencing a high degree of social vulnerability are also more exposed to wildfires in Oregon and Washington as wildfire risk increases, a new study shows.
Social vulnerability is a characteristic of a person or community, such as age, race or ethnicity or socioeconomic status, that affects their susceptibility to incur harm from a hazard.
From 2011 through 2021, the number of people with high social vulnerability who were exposed to wildfire in Oregon, Washington and California more than tripled compared to the previous decade. This compounding ...
Computational model helps with diabetes drug design
2023-09-20
CAMBRIDGE, MA -- For diabetes patients who must give themselves frequent insulin injections, the risk of low blood sugar can be life-threatening. A potential solution is a type of engineered insulin that circulates in the body and springs into action only when needed. Researchers working on this type of “glucose-responsive insulin” (GRI) hope that it could be injected less often and help the body maintain normal blood sugar levels for longer periods of time.
To help in the efforts to develop this kind of insulin, MIT engineers have created a computational model that ...
Lungs play a critical role in fetal blood development, new study from Boston Medical Center and Boston University’s Center for regenerative medicine finds
2023-09-20
BOSTON – A newly-released study by Boston Medical Center (BMC) and Boston University’s Center for Regenerative Medicine (CReM) found that the fetal lung is a potential source of hemogenic endothelial cells (HECs) that have the capacity to make blood. The findings broaden the understanding of where and how blood forms, which has the potential to enhance the treatment of blood-related diseases such as leukemia and lymphoma. Previously, no lung HECs had ever been detected.
“Our findings show that hemogenic endothelium, which was previously thought to be restricted to ...
LSU receives $5M from NOAA to build high-frequency radar systems on the coast
2023-09-20
From energy production to recreational fishing, Louisiana’s coastal waters are a busy place. Having reliable data about oceanic conditions can be critical to safe operations for those who work and play in coastal waters. Up until now, Louisiana’s Gulf Coast has been hampered by a lack of high-quality information about currents, waves and other important factors.
A new, LSU-led high-frequency radar project will change that.
This $5 million, NOAA (National Oceanic and Atmospheric Administration) funded project will install up to eight high-frequency radar, or HF radar, systems along the Louisiana coastline. Spearheaded by the ...
Texas Biomed launches new International Center for the Advancement of Research & Education
2023-09-20
SAN ANTONIO (Sept. 20, 2023) – Capitalizing on the power of its longstanding international partnership portfolio, Texas Biomedical Research Institute (Texas Biomed) has created a new global center to foster collaborations in infectious disease research.
The International Center for the Advancement of Research & Education (I·CARE) leverages the power of global exchange to solve complex health issues in an increasingly connected world. Texas Biomed currently maintains a portfolio of more than 15 international partnerships across Latin America, Africa, Asia and Europe. These partnerships are driving research in ...